The whys and hows of the nose

No "new" news here, but an informative look at in vitro testing considerations for nasal drug delivery written by Theo Kapanadze, chief scientific officer for Diteba Research Laboratories, based in Mississauga, Ontario. The first couple of sentences gives a brief, but surprisingly complete, historical overview of nasal drug delivery. "Drugs have been administered nasally for therapeutic and recreational purposes since ancient times. Psychotropic drugs and hallucinogens were snuffed for these purposes by the Indians of South America, and this practice is currently widespread among abusers of cocaine and heroin." Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.